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Introduction
Although infection risk associated with central venous
catheters (CVC) has reduced in recent years, the use of
CVC are still associated with relatively large number of
infections, leading to increased patient morbidity and
healthcare costs. A major source of microbial colonisa-
tion and infection of short term CVC is the patients’
endogenous skin microorganisms located at the catheter
insertion site.
Objectives
To evaluate the introduction and performance of a
chlorhexidine (CHG) gel CVC dressing in a critical care
environment.
Methods
Following Ethical committee and Trust approvals and staff
training, a transparent film-dressing incorporating an aqu-
eous CHG gel was introduced to critical care patients over
a 9 month period. Skin reactions to the dressings and per-
formance characteristics of the dressings were monitored.
Any adverse events were determined as per standard clini-
cal practice. Healthcare workers’ perceptions of the perfor-
mance of the dressing were evaluated at the end of the
study period.
Results
There were no reports of severe contact dermatitis asso-
ciated with the CHG or standard dressings. Close assess-
ment of skin condition at the CVC site was evaluated in
273 patients who had given their consent. Following
dressing removal, mild redness under the adhesive was
reported in one standard dressing group patient (0.7%,
n=137) and in seven CHG dressing group patients (5.1%,
n=136). Only one patient presented with mild redness
under the CHG gel part of the dressing (0.7%, n=136).
All the above symptoms resolved within 24 h following
dressing removal.
A questionnaire was distributed to critical care nur-
sing staff and clinicians in theatres, who had experience
handling and observing both the standard CVC (Tega-
derm IV dressing) and CHG gel containing CVC dres-
sing (CHG Tegaderm). In total, 71 nurses and 10
clinicians responded to the survey. Staff was satisfied
with the performance of the CHG dressing, with 97.5%
of the respondents rating the overall performance of the
CHG gel dressing as: the same as (11.1%), better (35.8%)
or much better (50.6%) than the standard CVC dressing.
Conclusion
The CHG gel CVC dressing was well tolerated by
patients and performed effectively in the critical care
environment.
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